Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia [8]

Bone Marrow Transplantation

Volumn 37, Issue 8, 2006, Pages 801-802

  Pieroni, Fabiano ^a   Oliveira, F M ^a   Panepucci, R A ^a   Voltarelli, J C ^a   Simoes B P ^a   Falcao R P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER REGRESSION; CASE REPORT; CHIMERA; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; FUSION GENE; GENE AMPLIFICATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPHENOTYPING; INGUINAL LYMPH NODE; KARYOTYPE; LETTER; LEUKEMOGENESIS; LIVING DONOR; LYMPHADENOPATHY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VARIABLE NUMBER OF TANDEM REPEAT;

BONE MARROW; HLA ANTIGENS; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; MINISATELLITE REPEATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TISSUE DONORS;

EID: 33645720261     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705332     Document Type: Letter

References (9)

1. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: A review. Blood 1994; 84: 3603-3612.
2. Fialkow PJ, Thomas ED, Bryant JI, Neiman PE. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971; 1: 251-255.
3. Matsunaga T, Murase K, Yoshida M, Fujimi A, Iyama S, Kuribayashi K et al. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. Am J Hematol 2005; 79: 294-298.
4. Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S et al. Development of leukemia in donor cells after allogeneic stem cell transplantation - a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005; 90: 969-975.
5. Bielorai B, Deeg HJ, Weintraub M, Neumann Y, Rosner E, Amariglio N et al. B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation. Bone Marrow Transplant 2003; 31: 931-934.
6. Brunstein CG, Hirsch BA, Hammerschmidt D, McGlennen RC, Nguyen PL, Verfaillie CM. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 2002; 29: 999-1003.
7. Cooley LD, Sears DA, Udden MM, Harrison WR, Baker KR. Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol 2000; 63: 46-53.
8. Au WY, Chan EC, Siu LL, Lau TC, Lie AK, Ma SK et al. Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol 2002; 119: 777-780.
9. Katz F, Reeves BR, Alexander S, Kearney L, Chessells J. Leukaemia arising in donor cells following allogeneic bone marrow transplantation for beta thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis. Br J Haematol 1993; 85: 326-331.